SENTI Trademark

Trademark Overview

On Wednesday, September 1, 2021, a trademark application was filed for SENTI with the United States Patent and Trademark Office. The USPTO has given the SENTI trademark a serial number of 97006723. The federal status of this trademark filing is REGISTERED as of Tuesday, September 10, 2024. This trademark is owned by Senti Biosciences, Inc.. The SENTI trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical or clinical use; genetic material for medical or clinical use; house mark for pharmaceutical products for human use, namely, pharmaceutical preparations for treating diseases through cell therapy and gene therapy
senti

General Information

Serial Number97006723
Word MarkSENTI
Filing DateWednesday, September 1, 2021
Status700 - REGISTERED
Status DateTuesday, September 10, 2024
Registration Number7502837
Registration DateTuesday, September 10, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 10, 2023

Trademark Statements

Goods and ServicesCells for medical or clinical use; genetic material for medical or clinical use; house mark for pharmaceutical products for human use, namely, pharmaceutical preparations for treating diseases through cell therapy and gene therapy
Translation of Words in MarkThe English translation of "SENTI" in the mark is "CENTS".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 14, 2021
Primary Code005
First Use Anywhere DateWednesday, May 1, 2024
First Use In Commerce DateWednesday, May 1, 2024

Trademark Owner History

Party NameSenti Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameSenti Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameSenti Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Saturday, September 4, 2021NEW APPLICATION ENTERED
Thursday, October 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 7, 2022ASSIGNED TO EXAMINER
Tuesday, June 7, 2022NON-FINAL ACTION WRITTEN
Tuesday, June 7, 2022NON-FINAL ACTION E-MAILED
Tuesday, June 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 1, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 1, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 10, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 10, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 30, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, September 1, 2023SOU EXTENSION 1 FILED
Friday, September 1, 2023SOU EXTENSION 1 GRANTED
Wednesday, March 6, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, March 6, 2024SOU EXTENSION 2 GRANTED
Friday, September 1, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 6, 2024SOU EXTENSION 2 FILED
Thursday, March 7, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2024USE AMENDMENT FILED
Monday, June 3, 2024TEAS STATEMENT OF USE RECEIVED
Friday, July 12, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, August 5, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 5, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 10, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, September 10, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Friday, July 12, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

senti pharmaceutical clinical therapy medical diseases treating through preparations cell gene